Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

Mitsui Chemicals showcases at FIND-DESIGN FAIR ASIA in Singapore new glass film, posica™ that improves view experience
Mitsui Chemicals showcases at FIND-DESIGN FAIR ASIA in Singapore new glass film, posica™ that improves view experience


Mitsui Chemicals, Inc. (Tokyo: 4183; President & CEO: HASHIMOTO Osamu) announced today that it will be exhibiting at the FIND-DESIGN FAIR ASIA, which is set to be held at Marina Bay Sands

Mitsui Chemicals showcases at FIND-DESIGN FAIR ASIA in Singapore new glass film, posica™ that improves view experience
Mitsui Chemicals showcases at FIND-DESIGN FAIR ASIA in Singapore new glass film, posica™ that improves view experience


Mitsui Chemicals, Inc. (Tokyo: 4183; President & CEO: HASHIMOTO Osamu) announced today that it will be exhibiting at the FIND-DESIGN FAIR ASIA, which is set to be held at Marina Bay Sands

Mitsui Chemicals showcases at FIND-DESIGN FAIR ASIA in Singapore new glass film, posica™ that improves view experience
Mitsui Chemicals showcases at FIND-DESIGN FAIR ASIA in Singapore new glass film, posica™ that improves view experience


Mitsui Chemicals, Inc. (Tokyo: 4183; President & CEO: HASHIMOTO Osamu) announced today that it will be exhibiting at the FIND-DESIGN FAIR ASIA, which is set to be held at Marina Bay Sands

Fujitec Singapore Celebrates Its 50th Anniversary
Fujitec Singapore Celebrates Its 50th Anniversary


FUJITEC SINGAPORE CORPN. LTD. (Head Office: Bedok South Avenue, Singapore; Managing Director William Wong), a group subsidiary of FUJITEC CO., LTD. (Head Office: Shiga Prefecture, Japan; President

GenSight Biologics reports 5 years’ data showing sustained efficacy and safety following one-time treatment with LUMEVOQ®
GenSight Biologics reports 5 years’ data showing sustained efficacy and safety following one-time treatment with LUMEVOQ®


Regulatory News:


This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220719006077/en/



Figure 1. Evolution of BCVA In LUMEVOQ®-treated


GLORY Invests in North America Fintech Clip Money Inc. to Deliver Enhanced Deposit Services for Businesses
GLORY Invests in North America Fintech Clip Money Inc. to Deliver Enhanced Deposit Services for Businesses


Glory, a global leader in cash technology solutions to the financial and retail industries, today announced their participation in the latest fundraising round by Clip Money Inc. (TSXV: CLIP) a

GLORY Invests in North America Fintech Clip Money Inc. to Deliver Enhanced Deposit Services for Businesses
GLORY Invests in North America Fintech Clip Money Inc. to Deliver Enhanced Deposit Services for Businesses


Glory, a global leader in cash technology solutions to the financial and retail industries, today announced their participation in the latest fundraising round by Clip Money Inc. (TSXV: CLIP) a

GLORY Invests in North America Fintech Clip Money Inc. to Deliver Enhanced Deposit Services for Businesses
GLORY Invests in North America Fintech Clip Money Inc. to Deliver Enhanced Deposit Services for Businesses


Glory, a global leader in cash technology solutions to the financial and retail industries, today announced their participation in the latest fundraising round by Clip Money Inc. (TSXV: CLIP) a

DGAP-News: BP appoints Goldman Sachs joint corporate broker
DGAP-News: BP appoints Goldman Sachs joint corporate broker
DGAP-News: BP appoints Goldman Sachs joint corporate broker
DGAP-News: BP appoints Goldman Sachs joint corporate broker
DGAP-News: BP appoints Goldman Sachs joint corporate broker
DGAP-News: BP appoints Goldman Sachs joint corporate broker
Granite Announces First Quarter Results and the Closing of $193.6 Million of New Acquisitions
Granite Announces First Quarter Results and the Closing of $193.6 Million of New Acquisitions


Granite Real Estate Investment Trust and Granite REIT Inc. (TSX: GRT.UN; NYSE: GRP.U) (“Granite” or the “Trust”) announced today its combined results for the three month period ended March 31, 2022

DGAP-News: BP p.l.c.: Transaction in Own Shares
DGAP-News: BP p.l.c.: Transaction in Own Shares
DGAP-News: BP p.l.c.: Transaction in Own Shares
DGAP-News: BP p.l.c.: Transaction in Own Shares
DGAP-News: BP p.l.c.: Transaction in Own Shares
DGAP-News: BP p.l.c.: Transaction in Own Shares
Evernorth Executive and Healthcare Services Industry Leader Joan Harvey Named to PAVmed Board of Directors
Evernorth Executive and Healthcare Services Industry Leader Joan Harvey Named to PAVmed Board of Directors


PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (the “Company” or “PAVmed”), a diversified commercial-stage medical technology company and parent of cancer prevention company Lucid Diagnostics Inc. (Nasdaq:

Sarah M. Ward Joins CI Financial Board of Directors
Sarah M. Ward Joins CI Financial Board of Directors


CI Financial Corp. (“CI”) (TSX: CIX; NYSE: CIXX) today announced the appointment of Sarah M. Ward to its Board of Directors, effective immediately. Ms. Ward is a lawyer with more than 35 years’

GenSight Biologics Reports Clinically Meaningful Vision Improvement is Maintained 4 Years After One-time Treatment with LUMEVOQ® Gene Therapy
GenSight Biologics Reports Clinically Meaningful Vision Improvement is Maintained 4 Years After One-time Treatment with LUMEVOQ® Gene Therapy


Regulatory News:


This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220123005091/en/



Figure 1. Evolution of BCVA In LUMEVOQ®-treated


GenSight Biologics Confirms Sustained Efficacy and Safety of Bilateral LUMEVOQ® Injections at 2-Year Follow-Up of REFLECT Phase III Trial
GenSight Biologics Confirms Sustained Efficacy and Safety of Bilateral LUMEVOQ® Injections at 2-Year Follow-Up of REFLECT Phase III Trial


Regulatory News:


This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20211213005948/en/



Figure 1. Best-Corrected Visual Acuity (BCVA) Change


FARO verbessert Gesundheitspflege von Zahnärzten und Patienten mit Hilfe der Solarspektrum-LED-Technologie – SunLike – von Seoul Semiconductor
FARO verbessert Gesundheitspflege von Zahnärzten und Patienten mit Hilfe der Solarspektrum-LED-Technologie – SunLike – von Seoul Semiconductor


Nach von Daten einer Forschungsstudie werden 30% der Zahnärzte in den nächsten 30 Jahren an einem Rückgang ihrer visuellen Fähigkeiten leiden. FARO verfügt bereits jetzt über Lösungen für dieses

FARO is Taking Care of the Healthcare of Dentists and Patients With the Solar Spectrum LED Technology – SunLike – From Seoul Semiconductor
FARO is Taking Care of the Healthcare of Dentists and Patients With the Solar Spectrum LED Technology – SunLike – From Seoul Semiconductor


From a research study 30% of dentists will suffer from visual reduction capabilities in the next 30 years. For FARO, the solutions are already here.


This press release features multimedia. View

HelloFresh lässt im Q3 Rekorde purzeln, aber...
HelloFresh lässt im Q3 Rekorde purzeln, aber...

Das September-Quartal konnte erneut mit Rekorden beendet werden. Und zwar erlöste HelloFresh (WKN: A16140) einen Gruppenumsatz von 970 Millionen Euro und damit 120 Prozent mehr als im dritten

HelloFresh: Neuer US-Clou!
HelloFresh: Neuer US-Clou!

HelloFresh (WKN: A16140) kleckert nicht, sondern klotzt und plant zwei neue Distributionszentren im Südosten der USA. Die Aktie durchläuft dagegen eine Schwächephase.

Bis zu 1.200 neue Mitarbeiter

Medios: Kurs crasht -16% nach Corona-Schock
Medios: Kurs crasht -16% nach Corona-Schock

Teurere Einkaufspreise schlagen zahlenmäßig heftig zu Buche und verderben Medios (WKN: A1MMCC) die Ergebnisentwicklung, worüber die Berliner Specialty-Pharma-Firma heute informiert. Die Aktie crasht

Phio: SD-Leser kassieren +224% bei Kursknall mit Ansage!
Phio: SD-Leser kassieren +224% bei Kursknall mit Ansage!

Unsere spekulative Aktie des Monats Mai liefert – und wie: Phio Pharmaceuticals (WKN: A2PYB0) knallt heute bis auf 6,48 USD in die Höhe. Damit stand ein Plus von +189% auf der Kurstafel.

„Es ist

CI Financial Corp. Announces Final Results of Substantial Issuer Bid
CI Financial Corp. Announces Final Results of Substantial Issuer Bid


CI Financial Corp. (TSX: CIX) (“CI Financial” or the “Corporation”) today announced the final results of its substantial issuer bid (the “Offer”) under which it has purchased for cancellation

Granite REIT Completes C$800 Million Offering of Senior Unsecured Debentures and Repayment of Its US$400 Million Term Loan
Granite REIT Completes C$800 Million Offering of Senior Unsecured Debentures and Repayment of Its US$400 Million Term Loan


Granite Real Estate Investment Trust (“Granite” or the “REIT”) (TSX: GRT.UN / NYSE: GRP.U) announced today that its wholly owned subsidiary Granite REIT Holdings Limited Partnership (“Granite LP”)